Identifying potentially inappropriate prescribing in older people with dementia: a systematic review

[1]  Yongqing Xu,et al.  Antegrade intramedullary nail versus plate fixation in the treatment of humeral shaft fractures , 2019, Medicine.

[2]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[3]  D. Aarsland,et al.  Potentially inappropriate medications and drug–drug interactions in home‐dwelling people with mild dementia , 2017, International journal of geriatric psychiatry.

[4]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation , 2016, British Medical Journal.

[5]  J. Boland,et al.  Communication and support from health-care professionals to families, with dependent children, following the diagnosis of parental life-limiting illness: A systematic review , 2016, Palliative medicine.

[6]  C. Walshe,et al.  What are the views of hospital-based generalist palliative care professionals on what facilitates or hinders collaboration with in-patient specialist palliative care teams? A systematically constructed narrative synthesis , 2016, Palliative medicine.

[7]  J. Osterbrink,et al.  Polypharmacy, potentially inappropriate medication and cognitive status in Austrian nursing home residents: results from the OSiA study , 2016, Wiener Medizinische Wochenschrift.

[8]  Mary Jordan Samuel.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2015, Journal of the American Geriatrics Society.

[9]  K. Johnell.  Inappropriate Drug Use in People with Cognitive Impairment and Dementia: A Systematic Review , 2015, Current clinical pharmacology.

[10]  U. Dapp,et al.  Geriatric patients with cognitive impairment. , 2015, Deutsches Arzteblatt international.

[11]  J. Hanlon,et al.  Potentially Suboptimal Prescribing for Older Veteran Nursing Home Patients With Dementia , 2015, The Annals of pharmacotherapy.

[12]  S. Mitchell,et al.  Use of medications of questionable benefit in advanced dementia. , 2014, JAMA internal medicine.

[13]  Paul Gallagher,et al.  STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.

[14]  N. Pratt,et al.  Multiple Anticholinergic Medication Use and Risk of Hospital Admission for Confusion or Dementia , 2014, Journal of the American Geriatrics Society.

[15]  F. Murtagh,et al.  The challenges of uncertainty and interprofessional collaboration in palliative care for non-cancer patients in the community: A systematic review of views from patients, carers and health-care professionals , 2014, Palliative medicine.

[16]  S. Fereshtehnejad,et al.  Anti-Dementia Drugs and Co-Medication Among Patients with Alzheimer’s Disease , 2014, Drugs & Aging.

[17]  X. Gómez-Batiste,et al.  Optimizing drug therapy in patients with advanced dementia: A patient-centered approach , 2014 .

[18]  M. Lapeyre-Mestre,et al.  Potential underuse of analgesics for recognized pain in nursing home residents with dementia: A cross-sectional study , 2013, PAIN®.

[19]  J. Hayden,et al.  Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact , 2013, Journal of clinical pharmacy and therapeutics.

[20]  G. Onder,et al.  Polypharmacy and mortality among nursing home residents with advanced cognitive impairment: results from the SHELTER study. , 2013, Journal of the American Medical Directors Association.

[21]  O. Herber,et al.  The role of healthcare support workers in providing palliative and end-of-life care in the community: a systematic literature review. , 2013, Health & social care in the community.

[22]  L. Calvó-Perxas,et al.  Drug use in patients with dementia: a register-based study in the health region of Girona (Catalonia/Spain) , 2013, European Journal of Clinical Pharmacology.

[23]  M. Boustani,et al.  The 2012 update to the anticholinergic cognitive burden scale , 2013 .

[24]  Chris Gastmans,et al.  Trust in nurse–patient relationships , 2013, Nursing ethics.

[25]  W. Hoffmann,et al.  Cognitive impairment in primary ambulatory health care: pharmacotherapy and the use of potentially inappropriate medicine , 2013, International journal of geriatric psychiatry.

[26]  K. Yaffe,et al.  Ten‐Year Trajectory of Potentially Inappropriate Medications in Very Old Women: Importance of Cognitive Status , 2013, Journal of the American Geriatrics Society.

[27]  C. Brunelli,et al.  Treatments and prescriptions in advanced dementia patients residing in long-term care institutions and at home. , 2013, Journal of palliative medicine.

[28]  G. Onder,et al.  Inappropriate Drugs in Elderly Patients with Severe Cognitive Impairment: Results from the Shelter Study , 2012, PloS one.

[29]  O. Almeida,et al.  Use of Potentially Harmful Medications and Health-Related Quality of Life among People with Dementia Living in Residential Aged Care Facilities , 2012, Dementia and Geriatric Cognitive Disorders Extra.

[30]  G. Onder,et al.  Polypharmacy in nursing home residents with severe cognitive impairment: Results from the SHELTER Study , 2012, Alzheimer's & Dementia.

[31]  C. Goodman,et al.  Potentially Inappropriate Prescribing in Older People with Dementia in Care Homes , 2012, Drugs & Aging.

[32]  A. Abu-Hanna,et al.  Inappropriateness of Medication Prescriptions to Elderly Patients in the Primary Care Setting: A Systematic Review , 2012, PloS one.

[33]  R. Schulz,et al.  The impact of family caregivers on potentially inappropriate medication use in noninstitutionalized older adults with dementia. , 2012, The American journal of geriatric pharmacotherapy.

[34]  F. Sung,et al.  Association between polypharmacy and dementia in older people: A population‐based case–control study in Taiwan , 2012, Geriatrics & gerontology international.

[35]  Paul Gallagher,et al.  Inappropriate Prescribing , 2012, Drugs & Aging.

[36]  C. Campanelli.  American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2012 .

[37]  Martin Knapp,et al.  Donepezil and memantine for moderate-to-severe Alzheimer's disease. , 2012, The New England journal of medicine.

[38]  B. Iglseder,et al.  Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list , 2012, Wiener klinische Wochenschrift.

[39]  Denys T. Lau,et al.  Functional Decline Associated With Polypharmacy and Potentially Inappropriate Medications in Community-Dwelling Older Adults With Dementia , 2011, American journal of Alzheimer's disease and other dementias.

[40]  S. Rozenfeld,et al.  Inappropriate medication use among the elderly: a systematic review of administrative databases , 2011, BMC geriatrics.

[41]  M. Viitanen,et al.  Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the Dementia Study in Northern Norway , 2011, BMC geriatrics.

[42]  H. Kuo,et al.  Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. , 2011, British journal of clinical pharmacology.

[43]  Cornelius Katona,et al.  Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study , 2011, Journal of the American Geriatrics Society.

[44]  J. Cummings,et al.  Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology , 2011, BMC neurology.

[45]  B. Craig,et al.  Incident use and outcomes associated with potentially inappropriate medication use in older adults. , 2010, The American journal of geriatric pharmacotherapy.

[46]  B. Guthrie,et al.  The burden of psychotropic drug prescribingin people with dementia: a populationdatabase study. , 2010, Age and ageing.

[47]  Sven Schmiedl,et al.  Potentially inappropriate medications in the elderly: the PRISCUS list. , 2010, Deutsches Arzteblatt international.

[48]  A. Saykin,et al.  Differences in Medication Use in the Alzheimer’s Disease Neuroimaging Initiative , 2010, Drugs & aging.

[49]  C. Beer,et al.  Quality use of medicines in residential aged care. , 2010, Australian family physician.

[50]  C. Teljeur,et al.  Potentially inappropriate prescribing and cost outcomes for older people: a national population study. , 2010, British journal of clinical pharmacology.

[51]  S. Mitchell,et al.  Daily Medication Use in Nursing Home Residents with Advanced Dementia , 2010, Journal of the American Geriatrics Society.

[52]  Denys T. Lau,et al.  Polypharmacy and Potentially Inappropriate Medication Use Among Community-dwelling Elders With Dementia , 2010, Alzheimer disease and associated disorders.

[53]  A. Minassian,et al.  Reduction of suboptimal prescribing and clinical outcome for dementia patients in a senior behavioral health inpatient unit , 2009, International Psychogeriatrics.

[54]  Olav Spigset,et al.  The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients , 2009, Scandinavian journal of primary health care.

[55]  K. Yaffe,et al.  Contraindicated medication use among patients in a memory disorders clinic. , 2008, The American journal of geriatric pharmacotherapy.

[56]  J. Shega,et al.  Integrating Palliative Medicine into the Care of Persons with Advanced Dementia: Identifying Appropriate Medication Use , 2008, Journal of the American Geriatrics Society.

[57]  M. Boustani,et al.  Impact of anticholinergics on the aging brain: a review and practical application , 2008 .

[58]  P. Rabins,et al.  Medication use in nursing home residents with advanced dementia , 2008, International journal of geriatric psychiatry.

[59]  K. Steinhauser,et al.  Disparities in pain management between cognitively intact and cognitively impaired nursing home residents. , 2008, Journal of pain and symptom management.

[60]  P. Gallagher,et al.  STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. , 2008, International journal of clinical pharmacology and therapeutics.

[61]  L. Merle,et al.  Potentially inappropriate medications in the elderly: a French consensus panel list , 2007, European Journal of Clinical Pharmacology.

[62]  S. Rubin,et al.  A drug burden index to define the functional burden of medications in older people. , 2007, Archives of internal medicine.

[63]  R. Aparasu,et al.  Healthcare Outcomes Associated with Beers' Criteria: A Systematic Review , 2007, The Annals of pharmacotherapy.

[64]  Ś. Sen,et al.  Conflicts and Concordance Between Measures of Medication Prescribing Quality , 2007, Medical care.

[65]  B. Pollock,et al.  The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity , 2006, Journal of clinical pharmacology.

[66]  S. Zimmerman,et al.  Potentially inappropriate prescribing before and after nursing home admission among patients with and without dementia. , 2005, The American journal of geriatric pharmacotherapy.

[67]  D. Clark,et al.  Systematic review of the problems and issues of accessing specialist palliative care by patients, carers and health and social care professionals , 2004, Palliative medicine.

[68]  F. Grodstein,et al.  Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women , 2004, Neurology.

[69]  M. Beers,et al.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. , 2003, Archives of internal medicine.

[70]  S. Ruths,et al.  Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents , 2003, European Journal of Clinical Pharmacology.

[71]  S. Hawker,et al.  Appraising the Evidence: Reviewing Disparate Data Systematically , 2002, Qualitative health research.

[72]  K. Yaffe,et al.  Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. , 1998, JAMA.

[73]  M. Beers,et al.  Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. , 1997, Archives of internal medicine.

[74]  D B Reuben,et al.  Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. , 1991, Archives of internal medicine.

[75]  H. Brodaty,et al.  Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia , 2015, Drugs & Aging.

[76]  K. Hersberger,et al.  Inappropriate prescribing: a systematic overview of published assessment tools , 2013, European Journal of Clinical Pharmacology.

[77]  R. Payne,et al.  Polypharmacy and medicines optimisation: Making it safe and sound , 2013 .

[78]  J. Bell,et al.  Anticholinergic and sedative medicines - prescribing considerations for people with dementia. , 2012, Australian family physician.

[79]  T. Strandberg,et al.  Use of Inappropriate Medications and Their Prognostic Significance Among In-Hospital and Nursing Home Patients with and without Dementia in Finland , 2006, Drugs & aging.

[80]  P. Devi,et al.  Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital , 2011, European Journal of Clinical Pharmacology.